In vitro and in vivo local tolerability of a synergistic anti-tuberculosis drug combination intended for pulmonary delivery.

MLA

Ravon, Faustine, et al. “In Vitro and in Vivo Local Tolerability of a Synergistic Anti-Tuberculosis Drug Combination Intended for Pulmonary Delivery.” Journal of Applied Toxicology : JAT, vol. 43, no. 2, Feb. 2023, pp. 298–311. EBSCOhost, https://doi.org/10.1002/jat.4381.

APA

Ravon, F., Menchi, E., Lambot, C., Al Kattar, S., Chraibi, S., Remmelink, M., Fontaine, V., & Wauthoz, N. (2023). In vitro and in vivo local tolerability of a synergistic anti-tuberculosis drug combination intended for pulmonary delivery. Journal of Applied Toxicology : JAT, 43(2), 298–311. https://doi.org/10.1002/jat.4381

Chicago

Ravon, Faustine, Elena Menchi, Coralie Lambot, Sahar Al Kattar, Selma Chraibi, Myriam Remmelink, Véronique Fontaine, and Nathalie Wauthoz. 2023. “In Vitro and in Vivo Local Tolerability of a Synergistic Anti-Tuberculosis Drug Combination Intended for Pulmonary Delivery.” Journal of Applied Toxicology : JAT 43 (2): 298–311. doi:10.1002/jat.4381.